1. Palella FJ Jr, Delaney KM, Moorman AC, et al.: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study (HOPS) Investigators. N Engl J Med 1998, 19:182–188.
2. Bing EG, Burnam MA, Longshore D, et al.: Psychiatric disorders and drug use among HIV-infected adults in the US. Arch Gen Psychiatry 2001, 58:721–728.
3. Cook J, Cohen MH, Grey D, et al.: Effects of depressive symptoms and mental health quality of life on use of highly active antiretroviral therapy among HIV-seropositive women. J Acquir Immune Defic Syndr 2002, 30:401–409. This prospective, multicenter study found a very high prevalence of depression (73%) among HIV-positive women; depressive symptoms were predictive of lower HAART utilization.
4. Rosenberg SD, Goodman LA, Osher FC, et al.: Prevalence of HIV, hepatitis B and hepatitis C in people with severe mental illness. Am J Public Health 2001, 19:31–37.
5. Stewart DL, Zuckerman CJ, Ingle JM: HIV seroprevalence in a chronically mentally ill population. J Natl Med Assoc 1994, 86:519–523.